Login / Signup

Angiotensin II receptor blockers and bone fracture in chronic kidney disease patients: the Fukuoka kidney disease Registry Study.

Tomoya ShukuriKentaro NakaiShigeru TanakaShunsuke YamadaMasanori TokumotoKazuhiko TsuruyaToshiaki NakanoTakanari Kitazono
Published in: Clinical and experimental nephrology (2023)
The present study showed that administering ARB was significantly associated with a lower frequency of bone fracture history.
Keyphrases
  • angiotensin ii
  • angiotensin converting enzyme
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • soft tissue
  • body composition
  • patient reported